IMMUNIC INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$7.51
-3.66%
Yahoo Finance · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-13.1%
3 months
-46.7%
6 months
-22.2%
1 year
-4.2%
Year to date
+40.6%
52-week range
$5.10 – $16.90
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$102.5M
P/E
-0.9
P/B
0.8
P/S
—
Revenue
$0
Net income
-$111.57M
Diluted EPS
-3.88
Gross margin
—
Net margin
—
Return on equity
-157.90%
Total debt
$328K
Cash
$155.1M
Free cash flow
-$88.05M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $0 | -$34.1M | — | — | -$31.25M |
| Mar 31, 2026 | $0 | -$32.59M | — | — | -$17.3M |
| Dec 31, 2025 | $0 | -$19.3M | — | — | -$19.29M |
| Sep 30, 2025 | $0 | -$25.58M | — | — | -$20.21M |
| Jun 30, 2025 | $0 | -$26.82M | — | — | -$24.65M |
| Mar 31, 2025 | $0 | -$25.47M | — | — | -$21.82M |
| Dec 31, 2024 | $0 | -$25.18M | — | — | -$22.97M |
| Sep 30, 2024 | $0 | -$24.37M | — | — | -$20.85M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent IMUX news
All market newsNo ticker-linked stories are in the current archive.